Table 1 |
||||
|
Age, anthropometric data and clinical characteristics of the women studied |
||||
|
PsA N = 45 |
Ps N = 52 |
Control N = 98 |
P |
|
|
|
||||
|
Age (years) |
60.5 ± 8.7 |
61.4 ± 9.1 |
60.1 ± 8.4 |
0.95 |
|
Weight (kg) |
69.4 ± 8.9 |
71.1 ± 14.2 |
67.8 ± 11.2 |
0.19 |
|
Height (m) |
1.50 ± 0.7 |
1.50 ± 0.6 |
1.55 ± 0.6 |
0.97 |
|
BMI (kg/m2) |
29.1 ± 3.6 |
26.6 ± 6.2 |
28.1 ± 4.54 |
0.19 |
|
Within ideal weight range * |
||||
|
N (%) |
7 (15.6) |
9 (17.3) |
25 (25.5) |
0.29 |
|
Overweight† |
||||
|
N (%) |
17 (37.8) |
22 (42.3) |
40 (40.8) |
0.9 |
|
Obese‡ |
||||
|
N (%) |
21 (46.7) |
21 (40.4) |
33 (33.7) |
0.31 |
|
Ps Duration (years) |
24.8 ± 16.2 |
21.8 ± 17.8 |
- |
0.39 |
|
PsA Duration (years) |
11 ± 10.5 |
- |
- |
- |
|
PASI |
2.2 ± 3.3 |
3.2 ± 3.4 |
- |
0.22 |
|
HAQ |
0.7 ± 0.5§|| |
0.2 ± 0.3 |
0.1 ± 0.2 |
<0.001 |
|
DAS28 |
3.7 ± 1.4 |
- |
- |
- |
|
PsARC |
||||
|
N° of swollen joints |
3.2 ± 2.9 |
- |
- |
- |
|
N° of painful joints |
3.5 ± 3.4 |
- |
- |
- |
|
Global evaluation of patient (VAS) |
4 ± 2.8 |
- |
- |
- |
|
Global evaluation of physician (VAS) |
3.3 ± 2.4 |
- |
- |
- |
|
Years since of menopause |
12.7 ± 9.9 |
15.4 ± 10.9 |
12.1 ± 8.6 |
0.22 |
|
|
||||
|
*BMI 18.50 - 24.99 kg/m2; †BMI 25 - 29.99 kg/m2; ‡BMI ≥ 30 kg/m2 DAS28, disease activity score 28; HAQ, health assessment questionnaire; PASI, psoriasis area severity index; PsA, psoriatic arthritis; Ps, psoriasis; PsARC, psoriatic arthritis response criteria; VAS, visual analogue scale. §P < 0.001 (PsA vs. Ps) ||P < 0.001 (PsA vs. control) |
||||
|
Pedreira et al. Arthritis Research & Therapy 2011 13:R16 doi:10.1186/ar3240 |
||||
